ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 36 filers reported holding ESSA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $76,410 | -90.3% | 28,300 | -89.3% | 0.00% | -90.9% |
| Q1 2023 | $785,776 | +17.9% | 264,571 | 0.0% | 0.01% | +10.0% |
| Q4 2022 | $666,719 | -93.3% | 264,571 | -24.1% | 0.01% | -92.4% |
| Q2 2021 | $9,957,000 | -37.8% | 348,524 | -36.8% | 0.13% | -44.1% |
| Q1 2021 | $16,010,000 | +28.0% | 551,122 | -47.4% | 0.24% | +16.8% |
| Q4 2020 | $12,509,000 | +377.1% | 1,048,524 | +175.9% | 0.20% | +274.1% |
| Q3 2020 | $2,622,000 | – | 380,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |